藥用玻璃包裝市場機會、成長動力、產業趨勢分析及2025-2034年預測

全球醫藥玻璃包裝市場價值 2024 年將達到 219 億美元，預計 2025 年至 2034 年的複合年成長率將達到 10.1%。市場成長的激增是由全球對藥品的需求不斷成長，加上確保藥品安全和完整性的嚴格監管要求所推動的。隨著製藥業尋求高度可靠和無污染的包裝解決方案，玻璃因其優異的耐化學性、耐用性和非反應性而繼續受到關注。

生物製劑、疫苗和注射的日益普及進一步擴大了對專用玻璃包裝的需求，特別是 1 型硼矽酸鹽玻璃，它可以提供無與倫比的防化學反應和熱波動保護。政府和監管機構正在加強遵守嚴格的包裝標準，使玻璃成為關鍵藥物配方的首選。個人化醫療、細胞和基因療法的轉變也推動製造商開發創新和永續的玻璃包裝解決方案，以滿足高價值藥物和複雜生物製劑的需求。

隨著全球對永續性的關注度不斷提高，製藥公司正在投資環保和可回收的包裝替代品。輕質玻璃解決方案正在獲得發展動力，因為它們有助於降低運輸成本，同時保持藥物穩定性和保護的高標準。新興市場，尤其是亞太地區的新興市場，正在經歷藥品生產的強勁成長，導致學名藥和品牌藥對玻璃包裝的採用率更高。生物相似藥的興起和嚴格的序列化法規進一步要求玻璃包裝，以確保產品的可追溯性和安全性。

藥用玻璃包裝市場主要按材料類型分類，其中 1 型玻璃佔據主導地位。 2024 年，這一類別的市場規模將達到 90 億美元，這得益於生物製劑、疫苗和注射藥物儲存對硼矽酸鹽玻璃的需求不斷成長。 1 型玻璃因其優異的耐化學性、防止藥物污染和分解而受到廣泛青睞。強制要求在敏感配方中使用硼矽酸鹽玻璃的嚴格監管準則的實施繼續加速了其市場需求。

根據產品類型，市場包括小瓶、瓶子、注射器、安瓿瓶和其他包裝形式。瓶裝飲料是該領域的佼佼者，預計到 2024 年將創造 63 億美元的市場價值，這主要是由於慢性病的發病率不斷上升，從而推動了對糖漿等液體製劑的需求。許多此類製劑都需要琥珀色玻璃瓶來保護其免受紫外線照射，這進一步增加了對專用藥用玻璃包裝的需求。該行業正在經歷向輕質玻璃瓶的轉變，這種玻璃瓶在保持可回收性和法規遵從性的同時，也提供了物流成本效率。

北美仍然是藥用玻璃包裝市場的主導力量，光是美國在 2024 年的市場規模就將達到 68 億美元。美國高度發展的製藥業，加上生物製劑和疫苗產量和出口量的不斷增加，繼續推動對高品質玻璃包裝的巨大需求。由於製藥商優先考慮安全性、永續性和法規遵循性，美國將繼續保持其作為全球市場主要貢獻者的地位。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 藥品安全監理嚴格
    • 人口老化與慢性病
    • 全球醫藥需求不斷成長
    • 玻璃包裝技術進步
    • 偏好即用型包裝
  • 產業陷阱與挑戰
    • 脆弱性和破損風險
    • 玻璃包裝成本高
• 成長潛力分析
• 監管格局
• 技術格局
• 未來市場趨勢
• 差距分析
• 波特的分析
• PESTEL 分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按材料，2021 年至 2034 年

• 主要趨勢
• l型
• 類型 II
• 類型 III

第6章：市場估計與預測：按產品，2021 年至 2034 年

• 主要趨勢
• 西林瓶
• 瓶子
• 墨水匣和注射器
• 安瓿
• 其他

第7章：市場估計與預測：依藥物類型，2021 年至 2034 年

• 主要趨勢
• 注射藥物
• 口服藥物
• 外用藥物
• 眼科藥物

第 8 章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 通用的
• 品牌
• 生物

第9章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國

第10章：公司簡介

• Arab Pharmaceutical Glass
• Ardagh Group
• Beatson Clark
• Corning
• DWK Life Sciences
• Gerresheimer
• Glassco
• Nipro
• PGP Glass
• Schott
• SGD
• Shandong Medicinal Glass
• Stevanato Group
• Stoelzle Oberglas
• United Glass Company
• West Pharmaceutical Services

The Global Pharmaceutical Glass Packaging Market, valued at USD 21.9 billion in 2024, is projected to expand at a CAGR of 10.1% from 2025 to 2034. The surge in market growth is driven by the increasing demand for pharmaceuticals worldwide, coupled with stringent regulatory requirements ensuring drug safety and integrity. As the pharmaceutical industry seeks highly reliable and contamination-free packaging solutions, glass continues to gain traction due to its superior chemical resistance, durability, and non-reactive properties.

The rising adoption of biologics, vaccines, and injectables is further amplifying the need for specialized glass packaging, particularly Type 1 borosilicate glass, which offers unparalleled protection against chemical interactions and thermal fluctuations. Governments and regulatory bodies are reinforcing compliance with strict packaging standards, making glass the preferred choice for critical drug formulations. The shift toward personalized medicine and cell and gene therapies is also driving manufacturers to develop innovative and sustainable glass packaging solutions that cater to high-value drugs and complex biologics.

With an increasing global focus on sustainability, pharmaceutical companies are investing in eco-friendly and recyclable packaging alternatives. Lightweight glass solutions are gaining momentum as they help reduce transportation costs while maintaining high standards for drug stability and protection. Emerging markets, particularly in Asia-Pacific, are experiencing robust growth in pharmaceutical production, leading to higher adoption rates for glass packaging in both generic and branded drugs. The rise of biosimilars and stringent serialization regulations further necessitate the demand for glass packaging, ensuring product traceability and safety.

The pharmaceutical glass packaging market is primarily categorized by material type, with Type 1 glass dominating the segment. In 2024, this category accounted for USD 9 billion, fueled by the increasing demand for borosilicate glass in the storage of biologics, vaccines, and injectable drugs. Type 1 glass is widely preferred due to its superior chemical resistance, preventing drug contamination and degradation. The implementation of strict regulatory guidelines that mandate the use of borosilicate glass for sensitive formulations continues to accelerate its market demand.

Based on product type, the market includes vials, bottles, syringes, ampoules, and other packaging formats. Bottles lead the segment, generating USD 6.3 billion in 2024, primarily due to the rising prevalence of chronic diseases that drive demand for liquid formulations such as syrups. Many of these formulations require amber-colored glass bottles to protect them from UV exposure, further boosting the demand for specialized pharmaceutical glass packaging. The industry is witnessing a shift toward lightweight glass bottles, which provide cost efficiency in logistics while maintaining recyclability and regulatory compliance.

North America remains a dominant force in the pharmaceutical glass packaging market, with the United States alone generating USD 6.8 billion in 2024. The country's highly advanced pharmaceutical sector, along with increasing production and exports of biologics and vaccines, continues to drive significant demand for high-quality glass packaging. With pharmaceutical manufacturers prioritizing safety, sustainability, and regulatory compliance, the U.S. is set to retain its position as a key contributor to the global market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Stringent regulations on drug safety
    • 3.2.1.2 Aging population and chronic disease
    • 3.2.1.3 Rising global pharmaceutical demand
    • 3.2.1.4 Technological advancement in glass packaging
    • 3.2.1.5 Preference for ready to use packaging
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Fragility and breakage risks
    • 3.2.2.2 High cost of glass packaging
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Material, 2021 – 2034 (USD Billion & Kilo Tons)

• 5.1 Key trends
• 5.2 Type l
• 5.3 Type ll
• 5.4 Type lll

Chapter 6 Market Estimates and Forecast, By Product, 2021 – 2034 (USD Billion & Kilo Tons)

• 6.1 Key trends
• 6.2 Vials
• 6.3 Bottles
• 6.4 Cartridges & syringes
• 6.5 Ampoules
• 6.6 Others

Chapter 7 Market Estimates and Forecast, By Drug Type, 2021 – 2034 (USD Billion & Kilo Tons)

• 7.1 Key trends
• 7.2 Injectable drugs
• 7.3 Oral drugs
• 7.4 Topical drugs
• 7.5 Ophthalmic drugs

Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2034 (USD Billion & Kilo Tons)

• 8.1 Key trends
• 8.2 Generic
• 8.3 Branded
• 8.4 Biologic

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 (USD Billion & Kilo Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Arab Pharmaceutical Glass
• 10.2 Ardagh Group
• 10.3 Beatson Clark
• 10.4 Corning
• 10.5 DWK Life Sciences
• 10.6 Gerresheimer
• 10.7 Glassco
• 10.8 Nipro
• 10.9 PGP Glass
• 10.10 Schott
• 10.11 SGD
• 10.12 Shandong Medicinal Glass
• 10.13 Stevanato Group
• 10.14 Stoelzle Oberglas
• 10.15 United Glass Company
• 10.16 West Pharmaceutical Services